Ticker Details
Edwards Lifesciences Corp Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
IPO Date:	April 3, 2000
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$51.75B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.10 | 1.20%
Avg Daily Range (30 D):	$1.09 | 1.23%
Avg Daily Range (90 D):	$1.21 | 1.41%

Institutional Daily Volume
Avg Daily Volume:	1.46M
Avg Daily Volume (30 D):	3.4M
Avg Daily Volume (90 D):	3.82M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	30,007
Avg Institutional Trade:	$6.28M
Avg Institutional Trade (30 D):	$10.04M
Avg Institutional Trade (90 D):	$9.01M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$23.47M
Avg Closing Trade (30 D):	$69.22M
Avg Closing Trade (90 D):	$76.28M
Avg Closing Volume:	418.07K

News

Jul 9, 2026 @ 11:00 AM TRiCares Announces Initiation of TRICURE US IDE Pi... Source: Tricares Sas

Jun 16, 2026 @ 5:52 PM Edwards Lifesciences Stands Out As US Agency Eyes ... Source: Vandana Singh

Apr 24, 2026 @ 4:50 PM Edwards Lifesciences Stock Surges On Heart Valve D... Source: Vandana Singh

Feb 20, 2026 @ 5:02 AM ORBIMED Advisors Trims $125 Million Terns Stake Af... Source: Eric Trie

Feb 17, 2026 @ 9:00 AM Pulmonary Artery Catheter Market Size to Reach USD... Source: Sns Insider

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.74	$.42	$.66
Diluted EPS	$1.74	$.42	$.66
Revenue	$6.51B	$1.74B	$1.65B
Gross Profit	$5.07B	$1.35B	$1.29B
Net Income / Loss	$1B	$241.4M	$380.7M
Operating Income / Loss	$1.45B	$513.2M	$477.6M
Cost of Revenue	$1.44B	$392.4M	$362.6M
Net Cash Flow	$-380.3M	$462.2M	$-492M
PE Ratio

Splits
Jun 01, 2020	3:1
Dec 14, 2015	2:1
May 28, 2010	2:1